Keun-Yeong Jeong

Gachon University Korea, South

Keun-Yeong Jeong serves as the chief executive officer and chief technology officer of PearlsinMires. He received his Ph.D. in Medicine from Korea University, South Korea. He completed his postdoctoral fellowship at Yonsei University College of Medicine, South Korea. Prior to founding PearlsinMires, Dr. Jeong focused on investigating the treatment of cancer and general diseases. He has noticeable scientific achievements to his credit, including many peer-reviewed publications and patents. Dr. Jeong developed promotion methods for the treatment of solid cancers utilizing stem cells, radiation, and peptides. He is the founder of PearlsinMires and a primary contributor to a core technology related to the company’s anticancer drug platform.

2books edited

2chapters authored

Latest work with IntechOpen by Keun-Yeong Jeong

From surgery to chemotherapy and radiotherapy, attempts to conquer colorectal cancer have been ongoing for a century. Due to these efforts, the mortality rate of colorectal cancer has decreased by about 3% per year for the past 10 years. Progress in reducing mortality from colorectal cancer can be accelerated by improving screening and the use of standard care in all populations. In recent years, advanced knowledge and technologies for better efficiency in targeting colorectal cancer have been developed to improve conventional therapeutics or to propose new therapies as standard regimens. This book discusses diagnostics as well as surgical techniques using robotics, immunotherapy, and radiology-based therapy for colorectal cancer. The section on diagnostics provides information on proteomics, organoid culture techniques, and various candidate markers. The section on treatment discusses robotic surgical techniques for rectal cancer care and multidisciplinary approaches for colorectal cancer treatment. The book also examines the latest in supportive care from a nutritional and metabolic point of view.

Go to the book